Walking and foot-pressure biofeedback for people with diabetic peripheral neuropathy
Official title: Walking Function in Individuals With Diabetic Peripheral Neuropathy: Biomechanical Mechanisms and Implications for Clinical Outcomes and Gait Retraining
Run by Florida Institute for Human and Machine Cognition · NCT05965336 · Data updated 2026-11-12
This project will test whether real-time biofeedback about foot pressure and push-off can change walking patterns and improve walking function in adults with diabetic peripheral neuropathy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 45 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Florida Institute for Human and Machine Cognition Academic / other |
| Locations | 1 site (Pensacola, Florida) |
| Status | Recruiting |
| Started | December 5, 2024 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | August 18, 2026 |
| Trial ID | NCT05965336 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 45 or older with physician-diagnosed diabetic peripheral neuropathy who can walk 10 meters independently and have medical clearance to walk on a treadmill.
✕Probably not a fit
Patients with active foot ulceration, prior lower-extremity amputation, major foot deformities, Charcot osteoarthropathy, recent lower-extremity surgery, or those unable to walk independently are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study compares walking mechanics between adults with diabetic peripheral neuropathy (DPN) and healthy controls and then uses real-time gait and plantar-pressure biofeedback to attempt to modify walking patterns. Participants complete clinical and biomechanical evaluations including treadmill walking, plantar pressure measurements, and passive ankle stiffness testing. Those with DPN receive supervised biofeedback gait training to target reductions in harmful plantar pressures and to modify propulsion patterns while monitoring safety and tolerability. The study will report feasibility, safety outcomes, and preliminary effects on walking speed, step counts, and plantar pressure distribution.
Why it matters
Potential benefit: If successful, the approach could lower high plantar pressures, improve walking speed and mobility, and potentially reduce ulceration risk for people with DPN.
How similar studies have gone: Gait biofeedback has shown benefits in other populations, but targeted plantar-pressure biofeedback specifically for DPN is relatively novel and only preliminarily tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for All Participants: 1. Age 45+ years 2. Able to walk 10-meters independently without an assistive device 3. Sufficient cardiovascular and musculoskeletal health to walk on a treadmill for 1-minute at self-selected speed Inclusion Criteria for Participants with DPN: 1. Diagnosis of DM 2. Diagnosis of DPN by a physician 3. Foot examination within the past 6 months to document ambulatory status 4. Physician's clearance Exclusion Criteria for Healthy Able-Bodied Individuals: 1. History of neurologic disease 2. History of orthopaedic disease affecting the lower extremities 3. History of injury or pain affecting the lower extremity or walking function within the past 6 months Exclusion Criteria for All Participants: 1. History of amputation 2. Active ulceration 3. Medial column deformity 4. History of Charcot osteoarthropathy 5. History of posterior muscle group lengthening 6. History of lower extremity joint replacement 7. History of lower extremity and/or foot surgery affecting walking mechanics 8. Orthopaedic problems of the lower limbs or spine due to other medical conditions (not DM or DPN) that limit walking or cause pain during walking 9. Improper footwear for walking and community ambulation 10. Cardiovascular or medical condition affecting ability to walk safely 11. History of unexplained dizziness or fainting in the past 2 months 12. Allergy to adhesive tape or rubbing alcohol 13. Individuals who are pregnant, prisoners, or not yet adults 14. Inability to communicate with the investigators 15. Inability to provide written informed consent
Where it's running
-
Florida Institute for Human and Machine Cognition
Pensacola, Florida, United States Recruiting
Study contacts
- Principal investigator: Nicole Rendos, PhD — Research Scientist
- Study coordinator: Nicole Rendos, PhD
- Email: nrendos@ihmc.org
- Phone: (850) 202-4442
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of perturbation-based balance training vs conventional balance training for reactive stepping in adults with diabetic nerve damage
A 40-person study will test whether adding perturbation-based balance training helps adults with diabetic peripheral neuropathy react better to balance threats compared with standard balance training.
-
Ultrasound-guided nerve hydrodissection for diabetic leg nerves
A single ultrasound-guided nerve hydrodissection procedure is tested to see if it helps people with diabetic lower limb entrapment neuropathy feel less pain and have better nerve function.
-
Shortwave therapy for diabetic peripheral neuropathy
A one-center study will test whether shortwave therapy given for five days can improve nerve symptoms in adults with diabetic neuropathy compared to a sham treatment.
-
MinION sequencing to identify microbes in diabetic foot bone infections
This study will test a rapid MinION DNA sequencing method to identify bacteria, fungi, and resistance genes in infected diabetic foot wounds and compare the results with standard culture.
-
Intraneural Facilitation and Otago Exercise for Diabetic Peripheral Neuropathy
This study will test whether intraneural facilitation, the Otago exercise program, or a combination of both can improve balance, reduce neuropathic pain, and improve quality of life for people aged 50–75 with diabetic peripheral neuropathy.
-
Topical Capsadyn (palmitated capsaicin) for diabetic neuropathic foot pain
This study will test whether a topical Capsadyn cream can reduce foot pain in adults with diabetic peripheral neuropathy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.